The latest national drug tender seeks to curb destructive price competition while tightening quality requirements for generic medicines
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
$18 Million in Bribes: The Double Life of a Chinese Financial Official
The latest national drug tender seeks to curb destructive price competition while tightening quality requirements for generic…
Chinese pharma companies are still striking global deals, but rising regulatory pressure is forcing a rethink
China’s new drug procurement rules prioritise quality over price in a bid to curb cutthroat competition.
Zhang Cheng used dual IDs and a rented decoy home to hide his massive illicit wealth, sources say
Regulators have cited serious defects at more than 10 companies as Beijing tightens oversight of low-cost medicines and medical…
As Chinese drugmakers churn out a record number of novel therapies, industry experts urge an overhaul of pricing, insurance and…
